In this episode of The Feldman Protocol, Greg Mushen, a longtime technology and product leader turned independent health researcher, makes the case that disciplined thinking from Silicon Valley can meaningfully inform nutrition and metabolic health. The discussion also directly engages with debates raised by the Keto-CTA study, using it as a case example to examine data transparency, scientific criticism, and decision-making under uncertainty—alongside metabolic testing innovation, walking versus high-intensity exercise, protein prioritization, and Greg’s own body recomposition—through a skeptical, analytical lens.

🔥 This episode is sponsored by us -- Own Your Labs `http://ownyourlabs.com` -- private blood testing services.

🩸Over 300 blood tests

💰Extremely affordable

❤️ We love our customers

(Yes, we are literally funding the entire podcast from our own company -- so if you want to show your support, keep getting your private blood testing through our service. Thank you! 🙏)

🔗 CONNECT WITH DAVE FELDMAN:

Main Channel: `https://youtube.com/@realDaveFeldman`

X/Twitter: `https://x.com/realDaveFeldman`

Instagram: `https://instagram.com/realDaveFeldman`

Website: `https://thefeldmanprotocol.com`

⏱ Chapters

3:42 – Data gaps in modern science

10:02 – Greg’s tech career origins

17:01 – Dot-com crash lessons

24:08 – Product management under pressure

31:10 – Data vs intuition in products

38:12 – Toxic positivity at work

45:30 – Internal honesty and feedback

52:40 – Health wake-up moment

59:55 – Weight, aging, and motivation

1:07:10 – Mold exposure and health

1:14:21 – Walking as a strategy

1:21:30 – Step counts and fat loss

1:28:47 – Protein targets explained

1:35:50 – Satiety and energy balance

1:42:30 – Before-and-after perspective

1:49:40 – Training consistency

1:56:20 – Hiring a coach

2:03:10 – Volume and hypertrophy

2:10:30 – Sustainable habits

2:17:20 – Aging and strength

2:24:30 – Transparency in research

2:31:40 – Fraud and oversight

2:38:30 – Whistleblowers in science

2:55:30 – Where to find Greg

3:01:56 – Final reflections and wrap

#FeldmanProtocol #DaveFeldman #GregMushen #MetabolicHealth #ProductThinking #DataTransparency #ProteinIntake #WalkingForHealth #StrengthTraining #HealthAndTech

In this episode of The Feldman Protocol, a core question hangs over the conversation: how did so many clinicians and patients miss low-carb interventions for so long? Dave sits down with Doug Reynolds, founder of Low Carb USA and president of the Society of Metabolic Health Practitioners, as the guest makes the case for carbohydrate reduction in chronic disease, practitioner education gaps, cultural food traditions, patient-driven change, conference-based knowledge sharing, and why engineers often follow data over authority.

🔥 This episode is sponsored by us -- Own Your Labs `http://ownyourlabs.com` -- private blood testing services.

🩸Over 300 blood tests

💰Extremely affordable

❤️ We love our customers

(Yes, we are literally funding the entire podcast from our own company -- so if you want to show your support, keep getting your private blood testing through our service. Thank you! 🙏)

🔗 CONNECT WITH DAVE FELDMAN:

Main Channel: `https://youtube.com/@realDaveFeldman`

X/Twitter: `https://x.com/realDaveFeldman`

Instagram: `https://instagram.com/realDaveFeldman`

Website: `https://thefeldmanprotocol.com`

⏱ Chapters

3:02 – Fat, food, and first doubts

7:05 – Preserving meat traditions

11:02 – Cooking as commitment

15:03 – Culture vs convenience

19:02 – Career detours and Amway

24:03 – Discovering ketones

29:02 – First ribeye moment

34:02 – Engineers and data trust

39:05 – Questioning guidelines

45:02 – Forums over authority

51:21 – Conferences as catalysts

57:10 – Practitioner hesitation

1:02:28 – Patients leading change

1:08:15 – Education gaps in care

1:15:40 – Cultural resistance

1:21:39 – Scaling conferences

1:27:10 – Screening ideas

1:33:00 – Community momentum

1:39:40 – Measuring success

1:45:20 – Clinical anecdotes

1:51:21 – Sharing unfinished work

1:56:30 – Patient empowerment

2:01:39 – Insulin outcomes shift

2:02:28 – Lifestyle over mandates

2:03:56 – Why the message spreads

#FeldmanProtocol #DaveFeldman #DougReynolds #LowCarbUSA #MetabolicHealth #PodcastInterview #HealthDiscussion #SciencePodcast #NutritionTalk #PatientCare #MedicalEducation

In this episode of The Feldman Protocol, a provocative question anchors the conversation: how much of cardiovascular risk is about cholesterol itself versus the context it operates in? Guest **Josh Wageman, DPT, PA-C, PhD**—a clinical lipid specialist and researcher—makes the case for using metaphor, metabolic health, and imaging to think differently about risk. The discussion spans coronary calcium scoring, lipid particles, insulin and inflammation, endurance training extremes, neurodegeneration, and why communicating science clearly actually matters. 🔥 This episode is sponsored by us -- Own Your Labs `http://ownyourlabs.com` -- private blood testing services.🩸Over 300 blood tests💰Extremely affordable❤️ We love our customers(Yes, we are literally funding the entire podcast from our own company -- so if you want to show your support, keep getting your private blood testing through our service. Thank you! 🙏)🔗 CONNECT WITH DAVE FELDMAN:Main Channel: `https://youtube.com/@realDaveFeldman`X/Twitter: `https://x.com/realDaveFeldman`Instagram: `https://instagram.com/realDaveFeldman`Website: `https://thefeldmanprotocol.com`⏱ Chapters3:00 – Why metaphors matter in medicine9:32 – Josh’s unconventional training path15:48 – Overtraining, illness, and collapse21:56 – Thyroid failure and recovery28:10 – Learning endocrinology the hard way34:42 – From PT to lipid specialist41:05 – Why lipids became the focus47:22 – Humor as a teaching tool53:40 – Writing the “lipid neighborhood”1:00:02 – Four pillars of metabolic health1:06:18 – Insulin and context over numbers1:12:35 – Inflammation isn’t one thing1:18:52 – Drugs as a risk factor1:25:14 – Cholesterol doesn’t live on paper1:31:28 – CAC as a reality check1:37:44 – Zero CAC and residual risk1:43:59 – Genetics vs lifestyle1:50:12 – ApoB’s necessary role1:56:27 – Why plaque still forms2:02:41 – Extreme endurance and CAC2:08:55 – When fitness backfires2:15:10 – Imaging vs biomarkers2:21:26 – Dementia and lipid biology2:27:40 – Neurodegeneration as frontier2:33:55 – Teaching clinicians differently2:40:08 – Credentials vs trust2:46:22 – Patient-first frameworks2:52:36 – Science communication failures2:58:49 – Measuring what matters3:04:55 – Meaning beyond metrics3:11:10 – Legacy and patient impact3:15:42 – Where Josh wants research to go3:18:43 – Closing thoughts and gratitude#FeldmanProtocol #DaveFeldman #JoshWageman #Lipids #Cholesterol #MetabolicHealth #ApoB #CACScore #Endocrinology #PreventiveCardiology #HealthCommunication